- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有112家主力机构披露2026-06-30报告期持股数据，持仓量总计2.09亿股，占流通A股64.88%
- 波段诊断：
-
技术面诊股
诊断结果：4.8技术面打败了47%的股票
技术面评分前10的股票
近期的平均成本为38.23元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为38.23元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"38.23","date":1788424308,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，跑赢行业平均水平。
[{"date":"2026.09.04","stock":"0.11","trade":"-0.93","ind":"-0.30"},{"date":"2026.09.03","stock":"0.00","trade":"0.47","ind":"0.02"},{"date":"2026.09.02","stock":"-1.55","trade":"-1.26","ind":"-0.97"},{"date":"2026.09.01","stock":"0.60","trade":"0.61","ind":"-0.16"},{"date":"2026.08.31","stock":"-0.70","trade":"-2.01","ind":"0.86"},{"date":"2026.08.28","stock":"-1.10","trade":"-2.41","ind":"-0.11"},{"date":"2026.08.27","stock":"-0.08","trade":"0.32","ind":"1.13"},{"date":"2026.08.26","stock":"1.50","trade":"0.94","ind":"0.59"},{"date":"2026.08.25","stock":"1.00","trade":"2.08","ind":"0.19"},{"date":"2026.08.24","stock":"-2.13","trade":"-4.47","ind":"-0.59"},{"date":"2026.08.21","stock":"-6.86","trade":"-3.50","ind":"0.04"},{"date":"2026.08.20","stock":"10.01","trade":"9.12","ind":"0.24"},{"date":"2026.08.19","stock":"-1.93","trade":"-2.79","ind":"-2.40"},{"date":"2026.08.18","stock":"-0.69","trade":"-1.53","ind":"0.19"},{"date":"2026.08.17","stock":"-0.79","trade":"0.14","ind":"1.41"},{"date":"2026.08.14","stock":"-1.67","trade":"0.21","ind":"0.01"},{"date":"2026.08.13","stock":"2.85","trade":"2.00","ind":"-0.50"},{"date":"2026.08.12","stock":"-0.79","trade":"-0.04","ind":"0.32"},{"date":"2026.08.11","stock":"-1.21","trade":"1.19","ind":"-0.82"},{"date":"2026.08.10","stock":"0.43","trade":"1.35","ind":"0.67"},{"date":"2026.08.07","stock":"4.35","trade":"6.42","ind":"1.02"}]
西藏药业,上证指数,生物制品指数
压力支撑
该股压力位为38.12元，支撑位为37.79元。
[{"text":"\u538b\u529b\u4f4d","value":"38.12","date":1788451200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"37.79","date":1788451200,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.0资金面打败了30%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：09月04日 20:30
| 机构今日流向(万元) | -1654.16 | 机构5日流向(万元) | -6621.63 |
| 机构10日流向(万元) | -17827.22 | 机构20日流向(万元) | -31415.19 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量增加136.75万股，其中基金净增仓4家，主力净增仓36家，有一定的中长期投资价值。
截止2026-06-30，共112家主力机构（基金103家，QFII1家，一般法人8家），持仓量总计20911.36万股，占流通A股64.88%
其中，基金持仓与2025-12-31相比：
增仓：19家 ，增持 110.34万股
减仓：15家 ，减持 302.89万股
新出现在主力名单中：66家 ，持有664.65万股
从主力名单中消失：30家 ，原持有371.51万股
其中，基金持仓与2025-12-31相比：
增仓：19家 ，增持 110.34万股
减仓：15家 ，减持 302.89万股
新出现在主力名单中：66家 ，持有664.65万股
从主力名单中消失：30家 ，原持有371.51万股
消息面诊股
诊断结果：6.4消息面打败了85%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 西藏药业：9月3日获融资买入729.16万元
2026-09-04 - 西藏药业：9月2日获融资买入1160.94万元
2026-09-03 - 西藏药业：对公司整体利润的影响幅度相对可控
2026-09-02 - 西藏药业：已累计回购公司股份占总1.24% 成交金
2026-09-02 - 西藏药业：9月1日获融资买入1102.27万元
2026-09-02 - 西藏药业：8月份公司未进行股份回购
2026-09-01 - 西藏药业：公司将于9月1日召开2026年半年度业绩
2026-09-01 - 19家A股疫苗企业半年考：11家营收下滑，行业承压
2026-09-01 - 西藏药业：已回购400.01万股，使用资金总额1.
2026-09-01 - 西藏药业：8月31日获融资买入1707.55万元
2026-09-01
消息列表
| 利好 | 分红转增 | 10派11.460元(含税) | 2026-08-14 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-08-14 |
| 一般消息 | 重大事项 | 关联交易 | 2026-08-14 |
| 一般消息 | 高管变动 | 调整第九届董事会专门委员会 | 2026-08-12 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2026-06-30 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-04-17 |
| 一般消息 | 重大事项 | 关联交易 | 2026-04-14 |
| 一般消息 | 股东大会 | 年度股东大会 | 2026-03-31 |
| 利好 | 分红转增 | 10派8.760元(含税) | 2026-03-13 |
| 一般消息 | 重大事项 | 关联交易 | 2026-03-13 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-12-31 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 4条 | 0条 | 4条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：5.0行业面打败了66%的股票
生物制品行业最新资金流向
近10日来该行业走势总体向下，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势总体向下，明显跑输大盘。
[{"date":"2026.09.04","price":"-0.30","value":"-0.93"},{"date":"2026.09.03","price":"0.02","value":"0.47"},{"date":"2026.09.02","price":"-0.97","value":"-1.26"},{"date":"2026.09.01","price":"-0.16","value":"0.61"},{"date":"2026.08.31","price":"0.86","value":"-2.01"},{"date":"2026.08.28","price":"-0.11","value":"-2.41"},{"date":"2026.08.27","price":"1.13","value":"0.32"},{"date":"2026.08.26","price":"0.59","value":"0.94"},{"date":"2026.08.25","price":"0.19","value":"2.08"},{"date":"2026.08.24","price":"-0.59","value":"-4.47"},{"date":"2026.08.21","price":"0.04","value":"-3.50"},{"date":"2026.08.20","price":"0.24","value":"9.12"},{"date":"2026.08.19","price":"-2.40","value":"-2.79"},{"date":"2026.08.18","price":"0.19","value":"-1.53"},{"date":"2026.08.17","price":"1.41","value":"0.14"},{"date":"2026.08.14","price":"0.01","value":"0.21"},{"date":"2026.08.13","price":"-0.50","value":"2.00"},{"date":"2026.08.12","price":"0.32","value":"-0.04"},{"date":"2026.08.11","price":"-0.82","value":"1.19"},{"date":"2026.08.10","price":"0.67","value":"1.35"},{"date":"2026.08.07","price":"1.02","value":"6.42"}]
上证指数,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | *ST未名 | 53.41% | 7.85% | 5.0分 |
| 2 | 近岸蛋白 | 33.03% | -15.23% | 3.5分 |
| 3 | 康希诺 | 27.01% | -16.82% | 4.1分 |
| 4 | 百普赛斯 | 26.19% | -0.96% | 5.0分 |
| 5 | 诺诚健华 | 9.04% | 9.19% | 5.9分 |
| 6 | 卫光生物 | 7.09% | -2.16% | 5.5分 |
| 8 | 赛伦生物 | 5.11% | -0.92% | 5.2分 |
| 10 | 欧林生物 | 3.67% | -2.69% | 4.9分 |
| 12 | 博晖创新 | 2.63% | -1.17% | 5.2分 |
| 14 | 优宁维 | 2.04% | -3.25% | 5.2分 |
| 16 | 特宝生物 | 1.79% | -2.47% | 4.7分 |
| 18 | 甘李药业 | 0.59% | -0.40% | 5.4分 |
| 20 | 成大生物 | -0.58% | -3.04% | 4.3分 |
| 22 | 天坛生物 | -1.68% | -0.49% | 5.1分 |
| 24 | 康泰生物 | -2.10% | -3.23% | 4.9分 |
| 26 | 上海莱士 | -2.38% | -0.20% | 5.4分 |
| 28 | 华兰生物 | -2.90% | -0.84% | 5.5分 |
| 30 | 通化东宝 | -4.75% | -1.96% | 5.0分 |
| 32 | 禾元生物 | -5.57% | -4.94% | 5.3分 |
| 34 | 百奥泰 | -5.77% | -6.17% | 4.2分 |
| 36 | 荣昌生物 | -6.58% | 3.77% | 5.3分 |
| 38 | 长春高新 | -8.41% | -2.87% | 4.9分 |
| 40 | 康辰药业 | -8.83% | -2.34% | 4.8分 |
| 42 | 双成药业 | -9.98% | -3.85% | 5.2分 |
| 44 | 三生国健 | -10.20% | -0.96% | 5.2分 |
| 46 | 康弘药业 | -10.77% | -2.45% | 5.3分 |
| 48 | - | -11.63% | -3.17% | 分 |
| 50 | 艾迪药业 | -11.97% | -4.22% | 4.5分 |
| 52 | 义翘神州 | -14.78% | -9.78% | 4.6分 |
| 54 | 诺唯赞 | -16.02% | -7.71% | 4.9分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-06-30 ]公司经营
盈利能力：很强，居行业前列，两项指标的行业排名分别为 2/72 ， 3/72。
[{"date":"2026-06-30","value":"15.77","vol":"-8.07"},{"date":"2026-03-31","value":"7.76","vol":"-6.34"},{"date":"2025-12-31","value":"24.31","vol":"-12.02"},{"date":"2025-09-30","value":"19.33","vol":"-9.89"},{"date":"2025-06-30","value":"14.04","vol":"-3.57"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
15.77 | 7.76 | 24.31 | 19.33 | 14.04 |
| 行业(%) | -8.07 | -6.34 | -12.02 | -9.89 | -3.57 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"93.00","vol":"55.74"},{"date":"2026-03-31","value":"92.90","vol":"60.27"},{"date":"2025-12-31","value":"94.22","vol":"65.27"},{"date":"2025-09-30","value":"93.73","vol":"66.41"},{"date":"2025-06-30","value":"94.60","vol":"66.14"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
93.00 | 92.90 | 94.22 | 93.73 | 94.60 |
| 行业(%) | 55.74 | 60.27 | 65.27 | 66.41 | 66.14 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 32/72 ， 26/72。
[{"date":"2026-06-30","value":"-5.83","vol":"31.09"},{"date":"2026-03-31","value":"1.61","vol":"291.45"},{"date":"2025-12-31","value":"6.23","vol":"39.10"},{"date":"2025-09-30","value":"-3.96","vol":"44.93"},{"date":"2025-06-30","value":"2.23","vol":"6771.91"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-5.83 | 1.61 | 6.23 | -3.96 | 2.23 |
| 行业(%) | 31.09 | 291.45 | 39.10 | 44.93 | 6771.91 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"7.16","vol":"18.81"},{"date":"2026-03-31","value":"10.93","vol":"71.92"},{"date":"2025-12-31","value":"-10.78","vol":"36.03"},{"date":"2025-09-30","value":"-8.85","vol":"44.79"},{"date":"2025-06-30","value":"-8.96","vol":"5.12"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
7.16 | 10.93 | -10.78 | -8.85 | -8.96 |
| 行业(%) | 18.81 | 71.92 | 36.03 | 44.79 | 5.12 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，两项指标的行业排名分别为 4/72 ， 18/72。
[{"date":"2026-06-30","value":"0.24","vol":"0.14"},{"date":"2026-03-31","value":"0.11","vol":"0.06"},{"date":"2025-12-31","value":"0.54","vol":"0.30"},{"date":"2025-09-30","value":"0.40","vol":"0.21"},{"date":"2025-06-30","value":"0.32","vol":"0.13"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.24 | 0.11 | 0.54 | 0.40 | 0.32 |
| 行业(次) | 0.14 | 0.06 | 0.30 | 0.21 | 0.13 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.58","vol":"0.63"},{"date":"2026-03-31","value":"0.27","vol":"0.28"},{"date":"2025-12-31","value":"1.09","vol":"1.26"},{"date":"2025-09-30","value":"0.85","vol":"0.88"},{"date":"2025-06-30","value":"0.63","vol":"0.54"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.58 | 0.27 | 1.09 | 0.85 | 0.63 |
| 行业(次) | 0.63 | 0.28 | 1.26 | 0.88 | 0.54 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：较强，高于行业平均，两项指标的行业排名分别为 29/72 ， 3/72。
[{"date":"2026-06-30","value":"11.52","vol":"-1291.20"},{"date":"2026-03-31","value":"53.00","vol":"-144.81"},{"date":"2025-12-31","value":"32.69","vol":"12.60"},{"date":"2025-09-30","value":"25.73","vol":"0.21"},{"date":"2025-06-30","value":"30.94","vol":"-1377.57"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 11.52 | 53.00 | 32.69 | 25.73 | 30.94 |
| 行业 | -1291.20 | -144.81 | 12.60 | 0.21 | -1377.57 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.15","vol":"1.53"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.20","vol":"1.73"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.25","vol":"1.53"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.15 | - | 0.20 | - | 0.25 |
| 行业 | 1.53 | 0.00 | 1.73 | 0.00 | 1.53 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 15/72 ， 27/72。
[{"date":"2026-06-30","value":"2.87","vol":"5.55"},{"date":"2026-03-31","value":"2.88","vol":"6.58"},{"date":"2025-12-31","value":"2.83","vol":"5.74"},{"date":"2025-09-30","value":"3.02","vol":"5.95"},{"date":"2025-06-30","value":"2.94","vol":"6.47"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.87 | 2.88 | 2.83 | 3.02 | 2.94 |
| 行业 | 5.55 | 6.58 | 5.74 | 5.95 | 6.47 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"2.72","vol":"4.13"},{"date":"2026-03-31","value":"2.73","vol":"5.09"},{"date":"2025-12-31","value":"2.67","vol":"4.39"},{"date":"2025-09-30","value":"2.83","vol":"4.79"},{"date":"2025-06-30","value":"2.78","vol":"5.16"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
2.72 | 2.73 | 2.67 | 2.83 | 2.78 |
| 行业 | 4.13 | 5.09 | 4.39 | 4.79 | 5.16 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：一般，低于行业平均，两项指标的行业排名分别为 11/72 ， 16/72。
[{"date":"2026-06-30","value":"34.41","vol":"30.05"},{"date":"2026-03-31","value":"33.86","vol":"29.49"},{"date":"2025-12-31","value":"33.98","vol":"29.33"},{"date":"2025-09-30","value":"32.25","vol":"27.48"},{"date":"2025-06-30","value":"25.88","vol":"27.37"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
34.41 | 33.86 | 33.98 | 32.25 | 25.88 |
| 行业(%) | 30.05 | 29.49 | 29.33 | 27.48 | 27.37 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.57","vol":"1.38"},{"date":"2026-03-31","value":"0.55","vol":"2.52"},{"date":"2025-12-31","value":"0.56","vol":"1.42"},{"date":"2025-09-30","value":"0.53","vol":"0.57"},{"date":"2025-06-30","value":"0.35","vol":"1.24"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.57 | 0.55 | 0.56 | 0.53 | 0.35 |
| 行业(%) | 1.38 | 2.52 | 1.42 | 0.57 | 1.24 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"3.70","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"8.01","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"10.51","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"9.38","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"10.07","blueLineValue":"3.12","type":"YC"}]